800-TEMPLE-MED Schedule Appointment

Coverage of the Coronavirus Pandemic for the Week Ending May 20th

View All News

Temple University Health System’s preparations for and treatment of patients amidst the coronavirus pandemic continue to be part of the media’s COVID-19 coverage.

  • Tony S. Reed, MD, PhD, MBA, Executive Vice President and Chief Medical Officer of Temple University Health System, joined the Philadelphia Department of Public Health and leaders from other city hospitals in urging Philadelphians to take precautions due to the rising number of COVID cases in the city. Dr. Reed offered comments that were picked up by CNN and the Philadelphia Inquirer.
  • Thomas Fekete, MD, MACP, Thomas Durant Chair and Professor of Medicine and Professor of Microbiology and Immunology at the Lewis Katz School of Medicine at Temple University, offered insight to WHYY about a PCR test developed by Rutgers University scientists that identifies COVID-19 variants. Dr. Fekete discussed how this could help target monoclonal antibody treatments and how it could be beneficial from a public health perspective.
  • Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, Clinical Professor and Director of the Postgraduate Year Two Infectious Diseases Residency at the Temple University School of Pharmacy and Clinical Pharmacist Specialist in Infectious Diseases at Temple University Hospital, spoke with Healthline about a Canadian study that found about 1 in 10 people who are hospitalized with COVID-19 end up back in the hospital or pass away within a month. Dr. Gallagher, who was not involved in the study, emphasized that the research presents an opportunity to review and improve treatment protocols.
  • Dr. Gallagher also spoke with Healthline for an article about what’s next now that 1 million Americans have passed away from COVID-19.